跳至主要内容
临床试验/NCT04107207
NCT04107207已完成不适用

Pilot Study to Evaluate Effects of Kombucha as a Hyperglycemic Therapeutic Agent Within Diabetic Human Subjects

Georgetown University2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2019年11月11日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
12
试验地点
2
主要终点
Blood Sugar Levels

研究概览

简要总结

This study's primary objective is to determine the ability of Kombucha to impact blood sugar levels in patients with diabetes mellitus type II. The secondary objective is to determine the ability of Kombucha to impact blood pressure, and quality of life measures as measured by uniform questionnaire that includes: gut health, colds, infections, headaches, sleep, anxiety (GAD2), depression (PHQ2), skin health.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • S/he is above the age of 18
  • S/he has the ability to read, speak and write English
  • S/he has telephone access
  • S/he is diabetic and willing to check blood sugar levels every day
  • Hb A1c >7%
  • Possesses a glucometer

排除标准

  • Allergy to kombucha ingredients
  • Drinks kombucha regularly (>3time per week)

结局指标

主要结局

Blood Sugar Levels

时间窗: 10 weeks

outcome measure: mg/dL

次要结局

  • Gut health(10 weeks)
  • anxiety(10 weeks)
  • depression(10 weeks)
  • skin health(10 weeks)
  • vulvovaginal health(10 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验